Pentacam assessment of posterior lamellar grafts to explain hyperopization after Descemet's stripping automated endothelial keratoplasty.

PURPOSE: To evaluate changes in posterior corneal curvature as a possible cause of the hyperopic refractive shift observed after Descemet's stripping automated endothelial keratoplasty (DSAEK). DESIGN: Prospective, noncomparative, interventional case series. PARTICIPANTS: Thirty-four eyes of 29 patients with Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy. METHODS: A standard DSAEK procedure was performed in 34 eyes using the pull-through technique for graft delivery. When cataract was present (n = 7), phacoemulsification with posterior chamber intraocular lens implantation was combined. Each eye underwent Pentacam (Oculus, Wetzlar, Germany) evaluation 1, 3, and 12 months after surgery. Corneal graft thickness was calculated on Scheimpflug scans at 9 locations (1 central, 4 peripheral, and 4 mid peripheral). The mean radius of posterior corneal curvature (Rm) was recorded. At each postoperative examination time, manifest refraction was determined and compared with pre-DSAEK values in simple procedures or with intended postoperative refraction, if cataract surgery had been performed. MAIN OUTCOME MEASURES: Manifest refraction, Rm, and corneal graft thickness at 1, 3, and 12 months after surgery. RESULTS: The mean+/-standard deviation posterior corneal curvature was 6.5+/-0.56 mm before surgery and varied from 5.52+/-0.39 mm 1 month after surgery to 5.83+/-0.37 mm at 3 months after surgery and 5.92+/-0.35 mm at 12 months after surgery. The grafts were significantly thicker in the periphery and mid periphery than in the center at all examination times. Thickening diminished significantly over time at all locations. The average reduction of corneal thickness was higher at the edges (91.5 microm) than in the mid periphery (38.3 microm) or in the center (24.2 microm). The average postoperative spherical equivalent+/-standard deviation changed from -0.31+/-2.35 diopters (D) before surgery to 1.03+/-2.21 D 1 month after surgery, 0.61+/-2.07 D 3 months after surgery, and +0.31+/-2.03 D 12 months after surgery. CONCLUSIONS: The difference in thickness between center and periphery of the DSAEK graft induces a change in posterior corneal curvature, resulting in a hyperopic shift that decreases with time and is negligible for spectacle correction. However, when performing a triple procedure, intraocular lens selection should take into account the refractive change induced by DSAEK. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases.

Macular degeneration is the leading cause of blindness in developed countries. In the treatment of neovascular age-related macular degeneration, vascular endothelial growth factor (VEGF) has emerged as a key target for therapy. The intravitreal injection of anti-VEGF drugs has been widely employed to reduce the disease progression and improve the visual outcomes of the affected patients. However, each intravitreal inoculation poses a risk of several complications as infection, inflammation, endophthalmitis, intraocular inflammation, increase of intraocular pressure and vitreous hemorrhage. This short review evaluates the efficacy and the incidence of adverse drug reactions related to intravitreal administration of the main anti-VEGF drugs actually available: Bevacizumab, ranibizumab and aflibercept.